Medgenics Announces Encouraging Preliminary Data For Phase I/II Clinical Trial Of EPODURE In Renal Anemia
Medgenics (AIM: MEDG), is pleased to announce encouraging preliminary data for its Phase I/II clinical trial.
The landmark Phase I/II clinical trial of Medgenics’ EPODURE Biopump, for providing sustained treatment of anemia in subjects with chronic kidney disease, is underway. The current trial [...]